ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #13,843Hybrid

Transfusion and Apheresis Science

Acronym:trasci
•
Abbreviation (ISO):TRANSFUS. APHERESIS SCI
•
Identifier (ISSN):1473-0502(Print)/1878-1683(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
1.2– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Transfusion and Apheresis Science

WoS Q4
01341.7520181.4120191.2820201.7620212.620221.920231.420241.220251.22026
Annual Impact Factor Metric
Current (2026):1.2
Scopus SJR & RankScopus Q3
0.414
#13,843

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
69

69 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate14.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
202articles/year
8.87% Gold OA•81.33% Original Research

Aims & Scope

Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues. Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.

Topics Covered (Recognized by AI)
Medicine94.2%Biology83.2%Internal medicine77.3%Immunology72.2%Surgery51.8%Genetics51.2%Pathology37.5%Chemistry34.6%Platelet30%Biochemistry29%Psychology24.3%Psychiatry20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q4
Rank84/103
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q4
Rank83/103
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.2
Articles / Year136
Total Citations13
2025
IF1.2
Articles / Year196
Total Citations100
2024
IF1.4
Articles / Year152
Total Citations215
2023
IF1.9
Articles / Year176
Total Citations488
2022
IF2.596
Articles / Year197
Total Citations794

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,843Scopus Q3SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.414

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,884 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations587
3-Year Documents521
Citable Documents434

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Transfusion and Apheresis Science (acronym: trasci, abbr: TRANSFUS. APHERESIS SCI, ISSN: 1473-0502) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 2001. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.414 (Q3), an H-index of 69.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 202 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,884 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 688ed698-d2c0-433b-8242-e7029cc9011d
Database Updated: 2026-10-16